Follow
Kevin Schaarschuch
Kevin Schaarschuch
TU Dresden
No verified email - Homepage
Title
Cited by
Cited by
Year
Top2a identifies and provides epigenetic rationale for novel combination therapeutic strategies for aggressive prostate cancer
JS Kirk, K Schaarschuch, Z Dalimov, E Lasorsa, SY Ku, S Ramakrishnan, ...
Oncotarget 6 (5), 3136, 2015
662015
Co-regulators of androgen receptor transcriptional activity as a novel therapeutic target for advanced prostate cancer
KF Schaarschuch
State University of New York at Buffalo, 2014
12014
Determining the apoptotic pathways required for the EZH2 inhibitor, GSK-126, in a mouse model of B cell lymphoma.
E Lasorsa, K Schaarschuch, Z Dalimov, L Ellis
Cancer Research 74 (19), 2014
2014
TOP2a identifies and provides epigenetic rationale for novel combination therapeutic strategies for aggressive prostate cancer
K Schaarschuch, JS Kirk, Z Dalimov, E Lasorsa, G Azabdaftari, Q Hu, ...
Cell 3, 0, 0
The system can't perform the operation now. Try again later.
Articles 1–4